MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
AxoGen Total Liabilities 2011-2026 | AXGN
Annual Total Liabilities AxoGen
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.8 M | 99.8 M | 101 M | 94.4 M | 95.5 M | 78.2 M | 22.5 M | 13.2 M | 33.7 M | 31.4 M | 29.4 M | 27.6 M | 27.5 M | 23.1 M | 6.42 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | 6.42 M | 51.8 M |
Quarterly Total Liabilities AxoGen
| 2026-Q1 | 2025-Q4 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44.7 M | 92.8 M | 93.2 M | 90.8 M | 99.8 M | 92.6 M | 93.2 M | 93.4 M | 101 M | 96.8 M | 94.5 M | 92 M | 94.4 M | 94.1 M | - | 94.2 M | 95.5 M | 94.7 M | 91.8 M | 77.7 M | 78.2 M | 78.2 M | 78.2 M | 78.2 M | 22.5 M | 22.5 M | 22.5 M | 22.5 M | 13.2 M | 13.2 M | 13.2 M | 13.2 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 31.4 M | 31.4 M | 31.4 M | 31.4 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 6.42 M | 6.42 M | 6.42 M | 6.42 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 101 M | 6.42 M | 49.1 M |
Total Liabilities of other stocks in the Medical devices industry
| Issuer | Total Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
45.2 M | $ 4.35 | 1.16 % | $ 163 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
129 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
20 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
82.4 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
31.2 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
3.56 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.95 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
69.7 M | $ 11.65 | 1.79 % | $ 330 M | USA |
 |
Apollo Endosurgery
APEN
|
77.6 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
24.2 M | $ 1.02 | 0.99 % | $ 17.3 M | USA |
 |
Alphatec Holdings
ATEC
|
126 M | $ 8.04 | -2.84 % | $ 1.21 B | USA |
 |
Aziyo Biologics
AZYO
|
34.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
54.2 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
33.1 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
39.9 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
73.2 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.02 M | $ 2.29 | - | $ 50.5 M | USA |
 |
CryoLife, Inc.
CRY
|
461 M | - | -4.14 % | $ 702 M | USA |
 |
LENSAR
LNSR
|
83.7 M | $ 5.95 | -2.38 % | $ 71.2 M | USA |
 |
Cytosorbents Corporation
CTSO
|
38.3 M | $ 0.47 | 2.16 % | $ 29.2 M | USA |
 |
Pulmonx Corporation
LUNG
|
75.2 M | $ 1.54 | -0.65 % | $ 62.7 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
162 M | $ 17.91 | -2.5 % | $ 420 M | USA |
 |
Delcath Systems
DCTH
|
12.4 M | $ 10.83 | -1.77 % | $ 388 M | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Myomo
MYO
|
27.2 M | $ 1.02 | -0.97 % | $ 42.7 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.44 K | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
1.41 B | $ 75.68 | 2.51 % | $ 4.13 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
21.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
57.2 M | - | - | $ 462 M | USA |
 |
Orthofix Medical
OFIX
|
401 M | $ 9.57 | -10.98 % | $ 379 M |  Curacao |
 |
Neovasc
NVCN
|
14 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
12.2 M | - | 14.99 % | $ 929 K | USA |
 |
MiMedx Group
MDXG
|
86.1 M | $ 3.67 | 1.24 % | $ 542 M | USA |
 |
Profound Medical Corp.
PROF
|
11 M | $ 6.89 | 0.88 % | $ 208 M | Canada |
 |
Electromed
ELMD
|
10.6 M | $ 38.09 | -0.34 % | $ 322 M | USA |
 |
Butterfly Network
BFLY
|
101 M | $ 4.57 | 2.13 % | $ 1.13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
160 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
23.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Sintx Technologies
SINT
|
6.58 M | $ 2.43 | 1.67 % | $ 6.74 M | USA |
 |
GBS
GBS
|
5.44 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
730 M | $ 85.48 | 0.79 % | $ 11.6 B | USA |
 |
Insulet Corporation
PODD
|
1.68 B | $ 153.42 | -0.94 % | $ 10.8 B | USA |
 |
CONMED Corporation
CNMD
|
1.29 B | $ 36.13 | -3.02 % | $ 1.12 B | USA |
 |
Inspire Medical Systems
INSP
|
126 M | $ 42.27 | -3.58 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
1.66 B | $ 91.06 | 1.99 % | $ 3.16 B | USA |
 |
Invacare Corporation
IVC
|
544 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
3.36 B | $ 87.65 | 2.18 % | $ 51.3 B | USA |
 |
TransMedics Group
TMDX
|
595 M | $ 70.26 | 1.91 % | $ 2.39 B | USA |